These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 13111250)

  • 1. Effect of 2,2-bis (parachlorophenyl)-1,1-dichloroethane (DDD) on the adrenal cortex of the rat.
    STONER HB
    Nature; 1953 Dec; 172(4388):1044-5. PubMed ID: 13111250
    [No Abstract]   [Full Text] [Related]  

  • 2. [Research on fractional injury of adrenal cortex of the dog with 2,2-bis (parachlorophenyl)-1, 1-dichloroethane (DDD)].
    KUCHMEISTER H; PLIESS G; WILHELM W
    Acta Endocrinol (Copenh); 1955 Sep; 20(1):39-49. PubMed ID: 13275233
    [No Abstract]   [Full Text] [Related]  

  • 3. Further observations on effect on plasma 17-OH-corticosteroids in the dog of derivatives of 2,2-bis-(p-chlorophenyl)-1,1-dichloroethane (DDD, TDE).
    COBEY FA; TALIAFERRO I; HAAG HB
    Proc Soc Exp Biol Med; 1958 Mar; 97(3):491-4. PubMed ID: 13518314
    [No Abstract]   [Full Text] [Related]  

  • 4. Observations on the relation of chemical structure to the production of adrenal cortical atrophy or hypertrophy in the dog by derivatives of 2, 2-bis-(p-chlorophenyl)-1, 1-dichloroethane (DDD, TDE).
    LARSON PS; HENNIGAR GR; FINNEGAN JK; SMITH RB; HAAG HB
    J Pharmacol Exp Ther; 1955 Dec; 115(4):408-12. PubMed ID: 13272193
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on DDD, 2,2-bis (parachlorophenyl)-1,1-dichloroethane.
    NICHOLS J; HENNIGAR G
    Exp Med Surg; 1957; 15(4):310-6. PubMed ID: 13512333
    [No Abstract]   [Full Text] [Related]  

  • 6. Production of insulin sensitivity with the adrenocorticolytic drug DDD (2,2-bis (parachlorophenyl)-1,1-dichloroethane).
    NICHOLS J; GARDNER LI
    J Lab Clin Med; 1951 Feb; 37(2):229-38. PubMed ID: 14814349
    [No Abstract]   [Full Text] [Related]  

  • 7. Administration of DDD (2,2-bis (parachlorophenyl)-1,1-dichloroethane) to diabetics with hyaline vascular changes and hyperpolysaccharidemia.
    TORNBLOM N
    Acta Med Scand; 1959 May; 164(1):23-37. PubMed ID: 13660771
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of the drug DDD on adrenal cortical function in adult rats.
    BROWN JH
    Proc Soc Exp Biol Med; 1953 May; 83(1):59-62. PubMed ID: 13064176
    [No Abstract]   [Full Text] [Related]  

  • 9. Acute and chronic toxicity studies on 2,2-bis-(p-ethylphenyl)-1,1-dichloroethane (perthane).
    FINNEGAN JK; HENNIGAR GR; SMITH RB; LARSON PS; HAAG HB
    Arch Int Pharmacodyn Ther; 1955 Oct; 103(4):404-18. PubMed ID: 13283630
    [No Abstract]   [Full Text] [Related]  

  • 10. Adrenals and serum polysaccharides. II. Action of DDD on the serum polysaccharides in rabbit.
    TORNBLOM N
    Acta Med Scand; 1955 Dec; 153(2):149-51. PubMed ID: 13292185
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on derivatives of 2,2-bis-(p-chlorophenyl)-1,1-dichloroethane (DDD, TDE) with special reference to their effects on the adrenal cortex.
    BLEIBERG MJ; LARSON PS
    J Pharmacol Exp Ther; 1957 Dec; 121(4):421-31. PubMed ID: 13492157
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of DDD (1, 1-dichloro-2, 2-bis-(p-chlorophenyl)ethane) on the human adrenal; attempts to use an adrenal-destructive agent in the treatment of disseminated mammary and prostatic cancer.
    BLOCH HS; HITCHCOCK CR; HOELSCHER B; WILLIAMS WL; ZIMMERMANN B
    Cancer; 1956; 9(5):940-8. PubMed ID: 13364879
    [No Abstract]   [Full Text] [Related]  

  • 13. Administration of DDD (2, 2-bis(parachlorophenyl)-1, 1-dichloroethane) to diabetics with hyaline vascular changes and hyperpolysaccharidemia; a preliminary report.
    TORNBLOM N
    Acta Med Scand; 1956 Mar; 154(2):83-9. PubMed ID: 13313071
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe adrenal cortical atrophy (cytotoxic) and hepatic damage produced in dogs by feeding 2,2-bis(parachlorophenyl)-1,1-dichloroethane (DDD or TDE).
    NELSON AA; WOODARD G
    Arch Pathol (Chic); 1949 Nov; 48(5):387-94. PubMed ID: 18143915
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhibitory effect of perthane (2, 2-bis-[para-ethylphenyl]-1,1-dichloroethane) on adrenocortical function in human subjects.
    Taliaferro I; Leone L
    N Engl J Med; 1957 Oct; 257(18):855-60. PubMed ID: 13477401
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of DDD and some of its derivatives on plasma 17-OH-corticosteroids in the dog.
    COBEY FA; TALIAFERRO I; HAAG HB
    Science; 1956 Jan; 123(3187):140-1. PubMed ID: 13281493
    [No Abstract]   [Full Text] [Related]  

  • 17. An investigation into the effects of 2:2-bis-(p-chlorophenyl)-1:1-dichloroethane (D.D.D.) on the mouse adrenal cortex.
    D'ARCY PF
    J Pharm Pharmacol; 1954 Sep; 6(9):625-8. PubMed ID: 13192622
    [No Abstract]   [Full Text] [Related]  

  • 18. Excretion of urinary 17-hydroxycorticoids in dogs fed DDD.
    BROWN JH; GRIFFIN J; SMITH RB
    Metabolism; 1955 Nov; 4(6):542-4. PubMed ID: 13272599
    [No Abstract]   [Full Text] [Related]  

  • 19. [Influence of adrenal cortical atrophy induced by rhothane (DDD) on the submaxillary gland of the dog].
    OSORIO JA; KRAEMER A
    Acta Physiol Lat Am; 1959; 9():128-32. PubMed ID: 14429258
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of o,p' DDD on histology and 17-hydroxycorticosteroid output of the dog adrenal cortex.
    VILAR O; TULLNER WW
    Endocrinology; 1959 Jul; 65(1):80-6. PubMed ID: 13663851
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.